Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A neural network model delivers a highly prognostic protein signature in cancer stem cells that identifies relapse in stage III colorectal cancer patientsAnna Sturrock, Sanghee Cho, Manuela Salvucci, et al.
Nucleic Acids Research|October 1, 2024
Ribosome Quality Control mitigates the cytotoxicity of ribosome collisions induced by 5-FluorouracilSusanta Chatterjee, Parisa Naeli, Okan Onar, et al.
Cell Death and Differentiation|November 10, 2021
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolutionAndreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
Communications Biology|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative stateShania M Corry, Svetlana Sakhnevych, Noha Ehssan Mohamed, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal CancerManuela Salvucci, Maximilian L Würstle, Clare Morgan, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Oncotarget|March 24, 2018
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i>-mutant stage II and III colon cancerPhilip D Dunne, Helen G Coleman, Peter Bankhead, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A neural network model delivers a highly prognostic protein signature in cancer stem cells that identifies relapse in stage III colorectal cancer patientsAnna Sturrock, Sanghee Cho, Manuela Salvucci, et al.
Nucleic Acids Research|October 1, 2024
Ribosome Quality Control mitigates the cytotoxicity of ribosome collisions induced by 5-FluorouracilSusanta Chatterjee, Parisa Naeli, Okan Onar, et al.
Cell Death and Differentiation|November 10, 2021
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolutionAndreas Ulrich Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
Communications Biology|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative stateShania M Corry, Svetlana Sakhnevych, Noha Ehssan Mohamed, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal CancerManuela Salvucci, Maximilian L Würstle, Clare Morgan, et al.
Pageof 12